Multivariate analysis of prognostic factors in synovial sarcoma

Orthopedics

Volumn 32, Issue 11, 2009, Pages

  Koh, Kyoung Hwan ^a   Cho, Eun Yoon ^a   Kim, Dong Wook ^a   Seo, Sung Wook ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; METASTASIS; OVERALL SURVIVAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX DIFFERENCE; SYNOVIAL SARCOMA; TUMOR LOCALIZATION; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; CANCER STAGING; CONNECTIVE TISSUE TUMOR; DISEASE FREE SURVIVAL; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; CHILD; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; SARCOMA, SYNOVIAL; YOUNG ADULT;

EID: 70450200638     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20090922-12     Document Type: Article

References (20)

1. Andrassy RJ, Okcu MF, Despa S, Raney RB. Synovial sarcoma in children: surgical lessons from a single institution and review of the literature. J Am Coll Surg. 2001; 192(3):305-313. (Pubitemid 32208871)
2. Bergh P, Meis-Kindblom JM, Gherlinzoni F, et al. Synovial sarcoma: identification of low and high risk groups. Cancer. 1999; 85(12):2596-2607. (Pubitemid 29272746)
3. Ferrari A, Gronchi A, Casanova M, et al. Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution. Cancer. 2004; 101(3):627-634.
4. Lewis JJ, Antonescu CR, Leung DH, et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000; 18(10):2087-2094.
5. Machen SK, Easley KA, Goldblum JR. Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas. Am J Surg Pathol. 1999; 23(3):268-275.
6. Skytting B. Synovial sarcoma. A Scandinavian Sarcoma Group project. Acta Orthop Scand Suppl. 2000; (291):1-28.
7. Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol. 2000; 18(22):3794-3803. (Pubitemid 30846225)
8. Thompson RC Jr, Garg A, Goswitz J, Cheng EY, Clohisy DR, Dusenbery K. Synovial sarcoma. Large size predicts poor outcome. Clin Orthop Relat Res. 2000; (373):18-24.
9. Trassard M, Le Doussal V, Hacène K, et al. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol. 2001; 19(2):525-534. (Pubitemid 32112867)
10. Campbell C, Gallagher J, Dickinson I. Synovial sarcoma-towards a simplified approach to prognosis. ANZ J Surg. 2004; 74(9):727-731. (Pubitemid 39318657)
11. Wright PH, Sim FH, Soule EH, Taylor WF. Synovial sarcoma. J Bone Joint Surg Am. 1982; 64(1):112-122.
12. de Silva MV, McMahon AD, Reid R. Prognostic factors associated with local recurrence, metastases, and tumor-related death in patients with synovial sarcoma. Am J Clin Oncol. 2004; 27(2):113-121.
13. Guillou L, Benhattar J, Bonichon F, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004; 22(20):4040-4050. (Pubitemid 41185173)
14. ten Heuvel SE, Hoekstra HJ, Bastiaannet E, Suurmeijer AJ. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression. Appl Immunohistochem Mol Morphol. 2009; 17(3):189-195.
15. Singer S, Baldini EH, Demetri GD, Fletcher JA, Corson JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996; 14(4):1201-1208. (Pubitemid 26105527)
16. Deshmukh R, Mankin HJ, Singer S. Synovial sarcoma: the importance of size and location for survival. Clin Orthop Relat Res. 2004; (419):155-161. (Pubitemid 38269686)
17. Paulino AC. Synovial sarcoma prognostic factors and patterns of failure. Am J Clin Oncol. 2004; 27(2):122-127.
18. Hasegawa T, Yokoyama R, Matsuno Y, Shimoda T, Hirohashi S. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol. 2001; 32(3):257-263. (Pubitemid 32246798)
19. Izumi T, Oda Y, Hasegawa T, et al. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression. Am J Surg Pathol. 2007; 31(1):85-94. (Pubitemid 46036906)
20. Lisle JW, Eary JF, O'Sullivan J, Conrad EU. Risk assessment based on FDG-PET imaging in patients with synovial sarcoma. Clin Orthop Relat Res. 2009; 467(6):1605-1611.